References (Continued, Page 5)

Spanier, C., Frank, E., McEachran, A. B., Grochocinski, V. J., & Kupfer, D. J. (1996). The prophylaxis of depressive episodes in recurrent depression following discontinuation of drug therapy: Integrating psychological and biological factors. Psychological Medicine, 26, 461–475.

Spaulding, W. D. (1997). Cognitive models in a fuller understanding of schizophrenia. Psychiatry, 60, 341–346.

Sperling, W., Barocka, A., Kalb, R., Suss, S., & Katalinic, A. (1997). Influence of season on manifestation of schizophrenic subtypes. Psychopathology, 30, 200–207.

Spiker, D. G. (1985). The pharmacological treatment of delusional depression. American Journal of Psychiatry, 142, 430–436.

Spiker, D. G., & Kupfer, D. J. (1988). Placebo response rates in psychotic and nonpsychotic depression. Journal of Affective Disorders, 14, 21–23.

Srebnik, D., Livingston, J., Gordon, L., & King, D. (1995). Housing choice and community success for individuals with serious and persistent mental illness. Community Mental Health Journal, 31, 139–152.

Stahl, S. M. (1996). Essential psychopharmacology: Neuroscientific basis and clinical applications. New York: Cambridge University Press.

Stanton, A. H., Gunderson, J. G., Knapp, P. H., Frank, A. F., Vannicelli, M. L., Schnitzer, R., & Rosenthal, R. (1984). Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin, 10, 520–563.

Steffens, D. C., & Krishnan, K. R. (1998). Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions. Biological Psychiatry, 43, 705–712.

Stein, L. I., & Test, M. A. (1980). Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. Archives of General Psychiatry, 37, 392–397.

Stewart, J. W., Quitkin, F. M., McGrath, P. J., Amsterdam, J., Fava, M., Fawcett, J., Reimherr, F., Rosenbaum, J., Beasley, C., & Roback, P. (1998). Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Archives of General Psychiatry, 55, 334–343.

Strachan, A. M. (1986). Family intervention for the rehabilitation of schizophrenia: Toward protection and coping. Schizophrenia Bulletin, 12, 678–698.

Strakowski, S. M., Lonczak, H. S., Sax, K. W., West, S. A., Crist, A., Mehta, R., & Thienhaus, O. J. (1995). The effects of race on diagnosis and disposition from a psychiatric emergency service. Journal of Clinical Psychiatry, 56, 101–107.

Straub, R. E., MacLean, C. J., Martin, R. B., Ma, Y., Myakishev, M. V., Harris-Kerr, C., Webb, B. T., O'Neill, F. A., Walsh, D., & Kendler, K. S. (1998). A schizophrenia locus may be located in region 10p15-p11. American Journal of Medical Genetics, 81, 296–301.

Stuppaeck, C. H., Geretsegger, C., Whitworth, A. B., Schubert, H., Platz, T., Konig, P., Hinterhuber, H., & Fleischhacker, W. W. (1994). A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. Journal of Clinical Psychopharmacology, 14, 241–246.

Sullivan, G. M., Coplan, J. D., & Gorman, J. M. (1998). Psychoneuroendocrinology of anxiety disorders. Psychiatric Clinics of North America, 21, 397–412.

Suppes, T., Baldessarini, R. J., Faedda, G. L., Tondo, L., & Tohen, M. (1993). Discontinuation of maintenance treatment in bipolar disorder: Risks and implications. Harvard Review of Psychiatry, 1, 131–144.

Suppes, T., McElroy, S. L., Gilbert, J., Dessain, E. C., & Cole, J. O. (1992). Clozapine in the treatment of dysphoric mania. Biological Psychiatry, 32, 270–280.

Susser, E., Hoek, H. W., & Brown, A. (1998). Neurodevelopmental disorders after prenatal famine: The story of the Dutch Famine Study. American Journal of Epidemiology, 147, 213–216.

Susser, E., Neugebauer, R., Hoek, H. W., Brown, A. S., Lin, S., Labovitz, D., & Gorman, J. M. (1996). Schizophrenia after prenatal famine. Further evidence. Archives of General Psychiatry, 53, 25–31.

Susser, E. S., & Lin, S. P. (1992). Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944–1945. Archives of General Psychiatry, 49, 983–988.

Svrakic, D. M., Whitehead, C., Przybeck, T. R., & Cloninger, C. R. (1993). Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Archives of General Psychiatry, 50, 991–999.

Symonds, L. L., Olichney, J. M., Jernigan, T. L., Corey-Bloom, J., Healy, J. F., & Jeste, D. V. (1997). Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 251–258.

Tanzman, B. (1993). An overview of surveys of mental health consumers' preferences for housing and support services. Hospital and Community Psychiatry, 44, 450–455.

Tarrier, N., Barrowclough, C., Porceddu, K., & Fitzpatrick, E. (1994). The Salford Family Intervention Project: Relapse rates of schizophrenia at five and eight years. British Journal of Psychiatry, 165, 829–832.

Taylor, D. P., Carter, R. B., Eison, A. S., Mullins, U. L., Smith, H. L., Torrente, J. R., Wright, R. N., & Yocca, F. D. (1995). Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. Journal of Clinical Psychiatry, 56(Suppl. 6), 3–11.

Tessler, R., & Gamache, G. (1994). Continuity of care, residence, and family burden in Ohio. Milbank Quarterly, 72, 149–170.

Tessler, R. C., & Goldman, H. H. (1982). The chronically mentally ill. Cambridge, MA: Ballinger.

Thacker, H. L. (1997). Menopause. Primary Care, 24, 205–221.

Thakker, J., & Ward, T. (1998). Culture and classification: The cross-cultural application of the DSM-IV. Clinical Psychology Review, 18, 501–529.

Thase, M. E. (1993). Maintenance treatments of recurrent affective disorders. Current Opinions in Psychiatry, 6, 16–21.

Thase, M. E. (1995). Reeducative psychotherapies. In G. O. Gabbard (Ed.), Treatment of psychiatric disorders (pp. 1169–1204). Washington, DC: American Psychiatric Press.

Thase, M. E. (1996). The undertreatment of patients with depression. Depressive Disorders: Index and Review, 4, 1.

Thase, M. E. (1998). Depression, sleep, and antidepressants. Journal of Clinical Psychiatry, 59(Suppl. 4), 55–65.

Thase, M. E., Blomgren, S. L., Birkett, M. A., Apter, J. T., & Tepner, R. G. (1997a). Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. Journal of Clinical Psychiatry, 58, 16–21.

Thase, M. E., Greenhouse, J. B., Frank, E., Reynolds, C. F., III, Pilkonis, P. A., Hurley, K., Grochocinski, V., & Kupfer, D. J. (1997b). Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Archives of General Psychiatry, 54, 1009–1015.

Thase, M. E., & Howland, R. H. (1995). Biological processes in depression: An updated review and integration. In E. E. Beckham & W. R. Leber (Eds.), Handbook of depression (2nd ed., pp. 213–279). New York: Guilford Press.

Thase, M. E., Mallinger, A. G., McKnight, D., & Himmelhoch, J. M. (1992). Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression. American Journal of Psychiatry, 149, 195–198.

Thase, M. E., & Rush, A. J. (1995). Treatment resistant depression. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 1081–1097). New York: Raven Press.

Thase, M. E., & Rush, A. J. (1997). When at first you don't succeed: Sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry, 58(Suppl. 13), 23–29.

Thase, M. E., Simons, A. D., Cahalane, J., McGreary, J., & Harden, T. (1991). Severity of depression and response to cognitive behavior therapy. American Journal of Psychiatry, 148, 784–789.

Thase, M. E., & Sullivan, L. R. (1995). Relapse and recurrence of depression: A practical approach for prevention. CNS Drugs, 4, 261–277.

Thase, M. E., Trivedi, M. H., & Rush, A. J. (1995). MAOIs in the contemporary treatment of depression. Neuropsychopharmacology, 12, 185–219.

Thorn, G. R., Chosak, A., Baker, S. L., & Barlow, D. H. (1999). Psychological theories of panic disorder. In D. J. Nutt, J. C. Ballenger, & J. P. Lepine (Eds.), Panic disorder: Clinical diagnosis, management and mechanisms (pp. 93–108). London: Martin Dunitz Ltd.

Tignol, J. (1993). A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression. Journal of Clinical Psychopharmacology, 13, 18S–22S.

Toomey, R., Faraone, S. V., Simpson, J. C., & Tsuang, M. T. (1998). Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder. Journal of Nervous and Mental Disease, 186, 470–476.

Torrey, E. F., & Yolken, R. H. (1998). At issue: Is household crowding a risk factor for schizophrenia and bipolar disorder? Schizophrenia Bulletin, 24, 321–324.

Trainor, J., Shepard, M., Boydell, K. M., & Magura, S. (1997). Beyond the service paradigm: The impact and implications of consumer/survivor initiatives. Psychiatric Rehabilitation Journal, 21, 132–140.

Trugman, J. M. (1998). Tardive dyskinesia: Diagnosis, pathogenesis, and management. The Neurologist, 20, 90–93.

Tsuang, M., & Faraone, S. V. (1990). The genetics of mood disorders. Baltimore: Johns Hopkins University Press.

Tsuang, M. T., & Faraone, S. V. (1995). The case for heterogeneity in the etiology of schizophrenia. Schizophrenia Research, 17, 161–175.

Tsuang, M. T., Gilbertson, M. W., & Faraone, S. V. (1991). The genetics of schizophrenia. Current knowledge and future directions. Schizophrenia Research, 4, 157–171.

Turner, J. C., & TenHoor, W. J. (1978). The NIMH Community Support Program: Pilot approach to a needed social reform. Schizophrenia Bulletin, 4, 319–348.

Turner, R. J., & Lloyd, D. A. (1995). Lifetime trauma and mental health: The significance of cumulative adversity. Journal of Health and Social Behavior, 36, 360–376.

Turner, R. J., Wheaton, B., & Lloyd, D. A. (1995). The epidemiology of stress. American Sociological Review, 60, 104–125.

Ulbrich, P. M., Warheit, G. J., & Zimmerman, R. S. (1989). Race, socioeconomic status, and psychological distress: An examination of differential vulnerability. Journal of Health and Social Behavior, 30, 131–146.

Umbricht, D., & Kane, J. M. (1995). Risperidone: Efficacy and safety. Schizophrenia Bulletin, 21, 593–606.

U.S. Department of Education. (1998). Disability Forum Report–3. Housing and disability: Data needs, statistics and policy. Proceedings of the Third National Disability Statistics and Policy Forum. Washington, DC: National Institute on Disability and Rehabilitation Research.

U.S. Department of Health and Human Services. (1996). Physical activity and health: A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion.

U.S. Department of Housing and Urban Development. (1994). Worse case need for housing assistance in the U.S. in 1990 and 1991: A report to Congress. Washington, DC: HUD Office of Policy Development and Research.

Vaillant, G. E. (1977). Adaptation to life. New York: Basic Books.

Van Os, J., & Marcelis, M. (1998). The ecogenetics of schizophrenia: A review. Schizophrenia Research, 32, 127–135.

Van Os, J., & Selten, J. P. (1998). Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. British Journal of Psychiatry, 172, 324–326.

Van Os, J., Wright, P., & Murray, R. M. (1997). Follow-up studies of schizophrenia. I: Natural history and non-psychopathological predictors of outcome. European Psychiatry, 12, 327S–341S.

Van Putten, T., Marder, S. R., & Mintz, J. (1990). A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. Archives of General Psychiatry, 47, 754–758.

Van Putten, T., Marder, S. R., Mintz, J., & Poland, R. E. (1992). Haloperidol plasma levels and clinical response: A therapeutic window relationship. American Journal of Psychiatry, 149, 500–505.

Van Tosh, L., & del Vecchio, P. (in press). Consumer/survivor-operated self-help programs: A technical report. Washington, DC: U.S. Department of Health and Human Services.

Vanelle, J. M. (1997). Refractory schizophrenia: Historical and currently prevailing criteria and definitions. European Psychiatry, 12, 321S–326S.

Vaughan, S. C., & Oldham, J. M. (1997). Behavioral and adaptive functioning. In A. Tasman, J. Kay, & J. A. Lieberman (Eds.), Psychiatry, (Vol. 1, pp. 549–562). Philadelphia: W. B. Saunders.

Viguera, A. C., & Cohen, L. S. (1998). The course and management of bipolar disorder during pregnancy. Psychopharmacology Bulletin, 34, 339–346.

Vita, A., Dieci, M., Giobbio, G. M., Garbarini, M., Morganti, C., Braga, M., & Invernizzi, G. (1994). A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. Psychiatry Research, 53, 41–55.

Vogel, H. S., Knight, E., Laudet, A. B., & Magura, S. (1998). Double trouble in recovery. Self-help for people with dual diagnoses. Psychiatric Rehabilitation Journal, 21, 356–364.

Wachtel, H. (1990). The second-messenger dysbalance hypothesis of affective disorders. Pharmacopsychiatry, 23, 27–32.

Wahl, O. F., Borostovik, L., & Rieppi, R. (1995). Schizophrenia in popular periodicals. Community Mental Health Journal, 31, 239–248.

Wahl, O. F., & Harman, C. R. (1989). Family views of stigma. Schizophrenia Bulletin, 15, 131–139.

Walker, P. W., Cole, J. O., Gardner, E. A., Hughes, A. R., Johnston, J. A., Batey, S. R., & Lineberry, C. G. (1993). Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. Journal of Clinical Psychiatry, 54, 459–465.

Walters, V. L., Tognolini, R. Z., Rueda, H. M., Rueda, R. M., & Torres, R. G. (1997). New strategies for old problems: Tardive dyskinesia (TD). Review and report on severe TD cases treated with clozapine, with 12, 8 and 5 years of video follow-up. Schizophrenia Research, 28, 231–246.

Ward, K. E., Friedman, L., Wise, A., & Schulz, S. C. (1996). Meta-analysis of brain and cranial size in schizophrenia. Schizophrenia Research, 22, 197–213.

Ware, N. C., & Goldfinger, S. M. (1997). Poverty and rehabilitation in severe psychiatric disorders. Psychosocial Rehabilitation Journal, 21, 3–9.

Wehman, P. (1988). Supported employment: Toward equal employment opportunity for persons with severe disabilities. Mental Retardation, 26, 357–361.

Wehr, T. A., & Goodwin, F. K. (1987). Can antidepressants cause mania and worsen the course of affective illness? American Journal of Psychiatry, 144, 1403–1411.

Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660–669.

Weinberger, D. R. (1995). Schizophrenia as a neurodevelopmental disorder. In S. R. Hirsch & D. R. Weinberger (Eds.), Schizophrenia (pp. 293–323). Oxford, England, Cambridge, MA: Blackwell Science Ltd.

Weinberger, D. R., & Lipska, B. K. (1995). Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for common ground. Schizophrenia Research, 16, 87–110.

Weiner, R. D., & Krystal, A. D. (1994). The present use of electroconvulsive therapy. Annual Review of Medicine, 45, 273–281.

Weiss, J. M. (1991). Stress-induced depression: Critical neurochemical and electrophysiological changes. In J. Madden (Ed.), Neurobiology of learning, emotion, and affect (pp. 123–154). New York: Raven Press.

Weiss, E. L., Longhurst, J. G., & Mazure, C. M. (1999). Childhood sexual abuse as a risk factor for depression in women: Psychosocial and neurobiological correlates. American Journal of Psychiatry, 156, 816–828.

Weissman, M. M., Bland, R. C., Canino, G. J., Faravelli, C., Greenwald, S., Hwu, H. G., Joyce, P. R., Karam, E. G., Lee, C. K., Lellouch, J., Lepine, J. P., Newman, S. C., Oakley-Browne, M. A., Rubio-Stipec, M., Wells, J. E., Wickramaratne, P. J., Wittchen, H. U., & Yeh, E. K. (1997). The cross-national epidemiology of panic disorder. Archives of General Psychiatry, 54, 305–309.

Weissman, M. M., Bland, R., Joyce, P. R., Newman, S., Wells, J. E., & Wittchen, H. U. (1993). Sex differences in rates of depression: Cross-national perspectives. Journal of Affective Disorders, 29, 77–84.

Wells, K. B., Katon, W., Rogers, B., & Camp, P. (1994). Use of minor tranquilizers and antidepressant medications by depressed outpatients: Results from the Medical Outcomes Study. American Journal of Psychiatry, 151, 694–700.

Wells, K. B., Rogers, W., Burnam, A., Greenfield, S., & Ware, J. E., Jr. (1991). How the medical comorbidity of depressed patients differs across health care settings: Results from the Medical Outcomes Study. American Journal of Psychiatry, 148, 1688–1696.

Wells, K. B., Stewart, A., Hays, R. D., Burnam, M. A., Rogers, W., Daniels, M., Berry, S., Greenfield, S., & Ware, J. (1989). The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. Journal of the American Medical Association, 262, 914–919.

Wells, K. B., Sturm, R., Sherbourne, C. D., & Meredith, L. S. (1996). Caring for depression. Cambridge, MA: Harvard University Press.

Wender, P. H., Kety, S. S., Rosenthal, D., Schulsinger, F., Ortmann, J., & Lunde, I. (1986). Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Archives of General Psychiatry, 43, 923–929.

Westenberg, H. G. (1996). Developments in the drug treatment of panic disorder: What is the place of the selective serotonin reuptake inhibitors? Journal of Affective Disorders, 40, 85–93.

Wetzel, H., Szegedi, A., Hain, C., Wiesner, J., Schlegel, S., & Benkert, O. (1995). Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: Results of an open clinical trial and changes of neuroendocrinological and EEG parameters. Psychopharmacology, 119, 231–238.

Wible, C. G., Shenton, M. E., Hokama, H., Kikinis, R., Jolesz, F. A., Metcalf, D., & McCarley, R. W. (1995). Prefrontal cortex schizophrenia. A quantitative magnetic resonance imaging study. Archives of General Psychiatry, 52, 279–288.

Widiger, T. A., & Costa, P. T., Jr. (1994). Personality and personality disorders. Journal of Abnormal Psychology, 103, 78–91.

Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998). Natural course of schizophrenic disorders: A 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin, 24, 75–85.

Wilkinson, L. S., Killcross, S. S., Humby, T., Hall, F. S., Geyer, M. A., & Robbins, T. W. (1994). Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology, 10, 61–72.

Williams, J. W., Jr., Rost, K., Dietrich, A., Ciotti, M., Zyzanski, S., & Cornell, J. (1999). Primary care physicians’ approach to depressive disorders: Effects of physician specialty and practice structure. Archives of Family Medicine, 8, 58–67.

Wilt, S., & Olson, S. (1996). Prevalence of domestic violence in the United States. Journal of the American Medical Women's Association, 51, 77–82.

Wing, J. (1962). Institutionalization in mental hospitals. Journal of Social and Clinical Psychology, 1, 38–51.

Winokur, G., Coryell, W., Keller, M., Endicott, J., & Akiskal, H. (1993). A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Archives of General Psychiatry, 50, 457–465.

Wiser, A. K., Andreasen, N. C., O'Leary, D. S., Watkins, G. L., Boles Ponto, L. L., & Hichwa, R. D. (1998). Dysfunctional cortico-cerebellar circuits cause “cognitive dysmetria” in schizophrenia. Neuroreport, 9, 1895–1899.

Woods, B. T., & Yurgelun-Todd, D. (1991). Brain volume loss in schizophrenia: When does it occur and is it progressive? Schizophrenia Research, 5, 202–204.

World Health Organization. (1997). Psychosocial rehabilitation: A consensus statement. International Journal of Mental Health, 26, 77–85.

Wyatt, R. J., Damiani, L. M., & Henter, I. D. (1998). First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment. British Journal of Psychiatry. Supplement, 172, 77–83.

Wyatt, R. J., Green, M. F., & Tuma, A. H. (1997). Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: A re-analysis of the Camarillo State Hospital data. Psychological Medicine, 27, 261–268.

Wyatt, R. J., & Henter, I. D. (1998). The effects of early and sustained intervention on the long-term morbidity of schizophrenia. Journal of Psychiatric Research, 32, 169–177.

Yehuda, R. (1999). Biological factors associated with susceptibility to post-traumatic stress disorder. Canadian Journal of Psychiatry, 44, 34–39.

Yolken, R. H., & Torrey, E. F. (1995). Viruses, schizophrenia, and bipolar disorder. Clinical Microbiology Reviews, 8, 131–145.

Yuen, O., Caligiuri, M. P., Williams, R., & Dickson, R. A. (1996). Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures. British Journal of Psychiatry, 168, 702–708.

Zaharia, M. D., Kulczycki, J., Shanks, N., Meaney, M. J., & Anisman, H. (1996). The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: Genetic and maternal factors. Psychopharmacology, 128, 227–239.

Zalewski, C., Johnson-Selfridge, M. T., Ohriner, S., Zarrella, K., & Seltzer, J. C. (1998). A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients. Schizophrenia Bulletin, 24, 127–145.

Zealberg, J. J., Hardesty, S. J., Meisler, N., & Santos, A. B. (1997). Mobile psychiatric emergency medical services. In S. W. Henggeler & A. B. Santos (Eds.), Innovative approaches for difficult-to-treat populations (pp. 263–273). Washington, DC: American Psychiatric Press.

Zornberg, G. L., & Pope, H. G., Jr. (1993). Treatment of depression in bipolar disorder: New directions for research. Journal of Clinical Psychopharmacology, 13, 397–408.

Zubin, J., & Spring, B. (1977). Vulnerability—a new view of schizophrenia. Journal of Abnormal Psychology, 86, 103–126.